Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia.
about
Microencapsulated Genetically EngineeredLactobacillus plantarum80 (pCBH1) for Bile Acid Deconjugation and Its Implication in Lowering CholesterolStructure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive reviewOptimal lipid modification: the rationale for combination therapyEvaluation of efficacy and safety of fixed dose lovastatin and niacin(ER) combination in asian Indian dyslipidemic patients: a multicentric studyCDA: combinatorial drug discovery using transcriptional response modulesControllability in cancer metabolic networks according to drug targets as driver nodesSystems Pharmacology and Rational Polypharmacy: Nitric Oxide-Cyclic GMP Signaling Pathway as an Illustrative Example and Derivation of the General CaseThe flavonoid luteolin inhibits niacin-induced flushA quercetin containing supplement reduces niacin-induced flush in humans.Management of dyslipidemia in women in the post-hormone therapy era.Niacin extended-release/lovastatin: combination therapy for lipid disorders.Niacin-ER and lovastatin treatment of hypercholesterolemia and mixed dyslipidemia.DIGRE: Drug-Induced Genomic Residual Effect Model for Successful Prediction of Multidrug Effects.Combination lipid-lowering therapy with statins: safety issues in the postcerivastatin era.New lipid-lowering agents.Extended-release niacin/lovastatin: the first combination product for dyslipidemia.A review of connectivity map and computational approaches in pharmacogenomics.Niacin-ER/statin combination for the treatment of dyslipidemia: focus on low high-density lipoprotein cholesterol.Finding multiple target optimal intervention in disease-related molecular network.A case study of single-pill combination therapy: the ezetimibe/simvastatin combination for treatment of hyperlipidemia.Time as a variable with niacin extended-release/lovastatin vs. atorvastatin and simvastatin.
P2860
Q24809565-C79C3F06-2609-490B-AE53-D1C00BCED810Q27008867-CCB30D0C-7CA8-4A33-A6B8-63CD0DECC809Q28219266-BF0FE735-A332-42BB-A09E-3EFB5BB2574AQ28219359-466FD3D3-B6BF-4014-BE49-42288CFC1174Q28482122-58E38E3C-42B8-4A0C-90B1-C84D05D12B44Q28535399-03CF3668-657B-401E-B7DB-F2095C23E779Q28550867-0817BD18-8991-49D2-A991-23B4EF09C21DQ34587640-9AAE9472-F78F-47D4-A35F-6BA01CAD73D2Q34597886-B7D56261-51F7-489F-ADEC-D74D3E9A62B9Q34722828-CE62377D-DB95-4457-BACE-A4F684E63BA1Q35020544-9CC5954D-212B-414B-92A1-4AED9565FBABQ35035100-251E3C4D-69F5-4C66-9AF4-030006A8E141Q35179543-D5DD9BC1-B56C-47BB-B414-9C9921376EA9Q35194386-4ECA79B7-3A2F-4A42-B544-F64AADB98371Q35602647-63F91491-A180-4F7E-B45F-DDF78191A01DQ35821875-9F0B1EA5-3E7C-4B7A-B21E-925179C7F624Q36244997-96B9CB29-CEAD-4747-A1C6-5AA53716A693Q36540320-1AFA86F1-B753-4F87-8661-4BAE8BE19A0AQ37170511-56AD7ED2-B3A5-47D0-9F62-391DE25A70B1Q38036194-9E1F9E73-60F9-4C8F-9E89-442D5B6B2C55Q46757874-91810E40-7702-4C95-B061-B0117F0049AE
P2860
Lovastatin and extended-release niacin combination product: the first drug combination for the management of hyperlipidemia.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Lovastatin and extended-releas ...... management of hyperlipidemia.
@ast
Lovastatin and extended-releas ...... management of hyperlipidemia.
@en
Lovastatin and extended-releas ...... management of hyperlipidemia.
@nl
type
label
Lovastatin and extended-releas ...... management of hyperlipidemia.
@ast
Lovastatin and extended-releas ...... management of hyperlipidemia.
@en
Lovastatin and extended-releas ...... management of hyperlipidemia.
@nl
prefLabel
Lovastatin and extended-releas ...... management of hyperlipidemia.
@ast
Lovastatin and extended-releas ...... management of hyperlipidemia.
@en
Lovastatin and extended-releas ...... management of hyperlipidemia.
@nl
P1476
Lovastatin and extended-releas ...... management of hyperlipidemia.
@en
P2093
Eric K Gupta
Matthew K Ito
P304
P356
10.1097/00132580-200203000-00010
P577
2002-03-01T00:00:00Z